Where can I buy Librela for dogs?

Librela must be prescribed and administered by your vet. Talk to your vet about getting your dog started on Librela.

How will I know when it's time for another Librela injection?

Librela is given once a month. When you begin treatments with Librela, you should be able to schedule regular monthly visits with your vet for future doses.

Is Librela safe for my dog?

Yes. Librela is approved as safe for dogs, but a conversation with your vet is the best way to confirm that Librela is right for your dog. For example, Librela should not be used in dogs with a sensitivity to the active ingredient, bedinvetmab. Librela also shouldn't be used in dogs who are pregnant, breeding, or lactating. The most common side effects that occurred in a clinical study were urinary tract infections, bacterial skin infections and dermatitis.

What is Librela for dogs?

Librela is the first and only anti-NGF monoclonal antibody for the control of OA pain in dogs. Librela is administered in the clinic as a once-monthly injection and was approved as safe and effective in clinical studies. Librela is an alternative treatment option to daily oral medications. Your veterinarian can determine if Librela is right for your dog.

How long does Librela take to work?

Although the effects of Librela may not be seen until after the second dose, some dogs may show a decrease in the signs of pain as soon as seven days after the first dose. With once-monthly injections, Librela provides long-lasting control of OA pain.

Librela

Give Dogs More Days of Play

Librela offers long-lasting pain relief with a once-monthly injection administered by your vet.¹

Osteoarthritis (OA), or arthritis, is a painful chronic condition of the joints. Pain from OA can severely affect the health and well-being of your dog.² Although we cannot cure OA, we can control the pain it causes.

Ask your vet about the newest osteoarthritis injection for dogs.

Are you missing the signs of your dog’s OA pain? Complete our quick checklist.

OA Checklist

One Monthly Injection of Librela Can Reduce Your Dog's OA Pain

By reducing OA pain and helping to restore mobility, Librela protects the unique bond they share with you.^1-4

Why Librela for Dogs?

By decreasing OA pain, Librela can increase your dog's activity and improve their quality of life.^{1, 3, 4}
Effectively controls Canine OA pain with a monthly injection.¹
Functions like naturally occurring antibodies that are easy on your dog's liver and kidneys.^{1, 5, 6}
Available in Europe since 2021, with over 4.6 million doses distributed.⁷

: How is Librela different from other pain management medications?
Librela is a monoclonal antibody that functions like your dog’s own naturally occurring antibodies.^{1, 5, 6} Your veterinarian will decide which type of OA medication is best for your dog. Ask your veterinarian if Librela is right for your dog.
It is important that your dog is at an ideal weight and is getting the proper amount of exercise to help manage OA pain. Your veterinarian will work with you on an OA pain management plan that best suits your dog.
: What to expect with Librela?
Although the effects of Librela may not be seen until after the second injection, some dogs will show a decrease in signs of OA pain as soon as seven days after the first injection.¹ Individual responses will vary.
: Can my dog receive Librela while they’re on other medication?
Before considering Librela, it’s always best to tell your veterinarian about any medication that your dog is receiving. Your veterinarian will decide what medications are safe to give at the same time as Librela.

Long-Lasting Relief From OA Pain Can Result in a Happier, More Active Dog

Relief from OA pain doesn’t just restore mobility, it renews happiness. By reducing pain, Librela can give you more precious moments in comfort with your best friend.^{1, 2} Talk to your vet about an OA screening and how treatment with Librela can make a big difference.

Vet-Approved Support

Librela FAQ

: Where can I buy Librela for dogs?
Librela must be prescribed and administered by your vet. Talk to your vet about getting your dog started on Librela.
: How will I know when it's time for another Librela injection?
Librela is given once a month. When you begin treatments with Librela, you should be able to schedule regular monthly visits with your vet for future doses.
: Is Librela safe for my dog?
Yes. Librela is approved as safe for dogs, but a conversation with your vet is the best way to confirm that Librela is right for your dog. For example, Librela should not be used in dogs with a sensitivity to the active ingredient, bedinvetmab. Librela also shouldn't be used in dogs who are pregnant, breeding, or lactating. The most common side effects that occurred in a clinical study were urinary tract infections, bacterial skin infections and dermatitis.¹
: What is Librela for dogs?
Librela is the first and only anti-NGF monoclonal antibody for the control of OA pain in dogs.¹ Librela is administered in the clinic as a once-monthly injection and was approved as safe and effective in clinical studies. Librela is an alternative treatment option to daily oral medications. Your veterinarian can determine if Librela is right for your dog.
: How long does Librela take to work?
Although the effects of Librela may not be seen until after the second dose, some dogs may show a decrease in the signs of pain as soon as seven days after the first dose.¹ With once-monthly injections, Librela provides long-lasting control of OA pain.⁸

IMPORTANT SAFETY INFORMATION: See full Prescribing Information. For use in dogs only. Women who are pregnant, trying to conceive or breastfeeding should take extreme care to avoid self-injection. Hypersensitivity reactions, including anaphylaxis, could potentially occur with self-injection. Librela should not be used in breeding, pregnant or lactating dogs. Librela should not be administered to dogs with known hypersensitivity to bedinvetmab. The most common adverse events reported in a clinical study were urinary tract infections, bacterial skin infections and dermatitis.

Librela (bedinvetmab injection). Prescribing information. NADA 141-562. Zoetis Inc; March 2023.
Lascelles BDX, Brown DC, Conzemius MG, Gill M, Oshinsky ML, Sharkey M. Measurement of chronic pain in companion animals: discussions from the Pain in Animals Workshop (PAW) 2017. Vet J. 2019;250:71-78. doi:10.1016/j. tvjl.2019.07.001.
Brown DC, Boston RC, Coyne JC, Farrar JT. Development and psychometric testing of an instrument designed to measure chronic pain in dogs with osteoarthritis. Am J Vet Res. 2007;68(6):631-637. doi:10.2460/ajvr.68.6.631.
Brown DC, Boston RC, Coyne JC, Farrar JT. Ability of the Canine Brief Pain Inventory to detect response to treatment in dogs with osteoarthritis. J Am Vet Med Assoc. 2008;233(8):1278-1283. doi:10.2460/ javma.233.8.1278.
Keizer RJ, Huitema AD, Schellens JH, Beijnen JH. Clinical pharmacokinetics of therapeutic monoclonal antibodies. Clin Pharmacokinet. 2010;49(8):493-507. doi:10.2165/11531280.
Olivry T, Bainbridge G. Advances in veterinary medicine: therapeutic monoclonal antibodies for companion animals. Zoetis. March 2015. https://www.zoetisus.com/conditions/dogs/itchcycle/downloads/ resources/publications/zoetiscn_mar_fnl.pdf.
Data on File. November 2022.
Corral, Maria J., et al. "A prospective, randomized, blinded, placebo-controlled multisite clinical study of bedinvetmab, a canine monoclonal antibody targeting nerve growth factor, in dogs with osteoarthritis." Veterinary anaesthesia and analgesia 48.6 (2021): 943-955. https://doi.org/10.1016/j.vaa.2021.08.001

ZPC-02734

The product information provided in this site is intended only for residents of the United States. The products discussed herein may not have marketing authorization or may have different product labeling in different countries. The animal health information contained herein is provided for educational purposes only and is not intended to replace discussions with an animal healthcare professional. All decisions regarding the care of a veterinary patient must be made with an animal healthcare professional, considering the unique characteristics of the patient.

#react-view{ margin-top: 2rem; } .nojs-message{ position: absolute; z-index: 10; top: 0; width: 100%; text-align: center; padding: 1rem; background: #d60000; color: white; font-weight: 700; font-size: 18px; } This site requires JavaScript. Your browser has JavaScript disabled, please turn it on in your browser settings.

The First and Only Monthly Monoclonal Antibody Injection to Control OA Pain1

Give Dogs More Days of Play

One Monthly Injection of Librela Can Reduce Your Dog's OA Pain

Why Librela for Dogs?

Long-Lasting Relief From OA Pain Can Result in a Happier, More Active Dog

Find Out if Your Dog is Showing Signs of OA

Understanding Your Dog’s OA Symptoms

Vet-Approved Support

Librela FAQ

The First and Only Monthly Monoclonal Antibody Injection to Control OA Pain¹